‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post-COVID bet on oncology

"The winners in life are differentiated from the losers in life because the winners never fall," Albert Bourla says. "The ...

Pfizer Balances Vaccine Expansion And Drug Discounts With Novavax And TrumpRx

Pfizer (NYSE:PFE) has entered a non exclusive licensing agreement with Novavax for access to its Matrix-M adjuvant technology. The company is also participating in the White House TrumpRx initiative, ...

Pfizer inks $530M deal for Novavax Matrix-M adjuvant technology to boost vaccine pipeline

Pfizer Inc. (NYSE:PFE) is one of the best inexpensive stocks to buy now. On January 20, Novavax announced a non-exclusive ...
CIDRAP

This year’s Pfizer COVID vaccine estimated to be 57% effective against emergency, urgent care

The 2025-26 Pfizer COVID-19 vaccine is about 57% effective against emergency department/urgent care (ED/UC) visits and 54% ...
Fierce Biotech

Pfizer pens $530M deal to use Novavax's vaccine adjuvant tech on 2 programs

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
Fierce Pharma

Pfizer retains top spot in vaccine maker rankings as Sanofi's slide sparks 'code red' call

But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good ...

Here's Why Pfizer Is Willing To Pay $500 Million For Novavax's Matrix-M

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Will Licensing Novavax’s Matrix-M Adjuvant Reshape Pfizer’s (PFE) Vaccine Platform Strategy?

Earlier in January 2026, Novavax announced a non-exclusive license and option agreement granting Pfizer worldwide rights to ...

Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19

Albert Bourla admitted to going to extreme lengths to “save the world” and get the vaccines out faster during the COVID-19 ...
Euractiv

Poland's Pfizer vaccine refusal lands in Brussels court, testing EU contract limits

A Brussels court is weighing whether Poland must pay Pfizer €1.4 billion for undelivered COVID vaccines, in a case that could ...
abc7NY

Pfizer's COVID-19 vaccine: What are the side effects? Who will get it first? Here's what we know

The US Food and Drug Administration has issued emergency use authorization (EUA) for the Covid-19 vaccine developed by Pfizer and BioNTech. After months of development, emergency use was authorized ...